1,283 results on '"Cortese, Bernardo"'
Search Results
2. Sirolimus-coated balloon in all-comer population of coronary artery disease patients: the EASTBOURNE DIABETES prospective registry
3. Balón liberador de sirolimus en el tratamiento del síndrome coronario agudo y crónico: el estudio PEACE, un subanálisis del registro EASTBOURNE
4. Sirolimus-coated balloon in acute and chronic coronary syndromes: the PEACE study, a subanalysis of the EASTBOURNE registry
5. Performance of sodium-glucose cotransporter 2 inhibitors in cardiovascular disease
6. Sirolimus-coated balloon versus drug-eluting stent for complex coronary lesions. A propensity matched comparison
7. Long-term impact of intravascular ultrasound-guidance for percutaneous coronary intervention on unprotected left main. The IMPACTUS-LM, an observational, multicentric study
8. Gender differences in the development of heart failure after acute coronary syndrome: Insight from the CORALYS registry
9. Clinical outcomes of a dedicated bifurcation stent system
10. Safety and efficacy of single antiplatelet therapy in a large cohort of patients treated with sirolimus-coated balloon: Post hoc analysis from the prospective EASTBOURNE registry
11. Angiographic and clinical impact of balloon inflation time in percutaneous coronary interventions with sirolimus-coated balloon: A subanalysis of the EASTBOURNE study
12. A Clinical Appraisal of Optical Coherence Tomography for Left Main Stem Intervention
13. Is There a Role for OCT for Left Main Assessment Before and After PCI?
14. A Prospective Randomized Trial Comparing Sirolimus-Coated Balloon With Paclitaxel-Coated Balloon in De Novo Small Vessels
15. Forecasting the Risk of Heart Failure Hospitalization After Acute Coronary Syndromes: the CORALYS HF Score
16. Design and rationale of a prospective, randomized, non-inferiority trial to determine the safety and efficacy of the Biolimus A9™ drug coated balloon for the treatment of in-stent restenosis: First-in-man trial (REFORM)
17. Comparison of Outcomes Between 1- and 2-Stent Techniques for Medina Classification 0.0.1 Coronary Bifurcation Lesions
18. Validation of a Contemporary Acute Kidney Injury Risk Score in Patients With Acute Coronary Syndrome
19. Sirolimus-Coated Balloon in an All-Comer Population of Coronary Artery Disease Patients: The EASTBOURNE Prospective Registry
20. Long-Term Outcome of Drug-Coated Balloon vs Drug-Eluting Stent for Small Coronary Vessels: PICCOLETO-II 3-Year Follow-Up
21. IncidenCe and predictOrs of heaRt fAiLure after acute coronarY Syndrome: The CORALYS registry
22. mTOR Inhibition by Drug-Coated Balloon
23. Impact of Clinical and Lesion Features on Outcomes After Percutaneous Coronary Intervention in Bifurcation Lesions
24. Small Vessel Coronary Artery Disease: Rationale for Standardized Definition and Critical Appraisal of the Literature
25. Gender differences in outcomes after left atrial appendage closure with Watchman FLX device: insights from the Italian-FLX registry.
26. The role of drug-coated balloons for coronary bifurcation management: results from the prospective EASTBOURNE-BIF study.
27. Drug-Eluting Balloons and Drug-Eluting Stents in Diabetic Patients Undergoing Percutaneous Coronary Intervention Due to Restenosis—DM-Dragon Registry.
28. Are we at dawn of the drug-coated balloons era? Current evidence, future directions, and tasks of the newly established working group of the Association of Cardiovascular Interventions.
29. Previous Mistakes with DCB Technology, and How to Prevent Them in the Future
30. The Use of Drug-Coated Balloons for Patients with In-Stent Restenosis
31. Cost/Effectiveness and Reimbursement Policies with Drug-Coated Balloons in Europe
32. History of Drug-Coated Balloons
33. Drug-Coated Balloons for Native Femoro-popliteal Disease
34. Dissection Management with Drug-Coated Balloons
35. Sirolimus-Coated Balloon: Insights on a New Technology for Coronary Use
36. Drug-Coated Balloons in Native Coronary Artery Disease
37. Balón recubierto con sirolimus por el tratamiento del síndrome coronario agudo y crónico: subanálisis del estudio EASTBOURNE
38. Long term clinical outcome of sirolimus drug coated balloons in large coronary vessels
39. Drug-coated balloons on the �big stage�: is this technology ready for an all-comer population with de novo lesions?
40. A 2024 scientific update on the clinical performance of drug-coated balloons
41. Benefit of Extended Dual Antiplatelet Therapy Duration in Acute Coronary Syndrome Patients Treated with Drug Eluting Stents for Coronary Bifurcation Lesions (from the BIFURCAT Registry)
42. Long-term (≥15 years) Follow-up of Percutaneous Coronary Intervention of Unprotected Left Main (From the GRAVITY Registry)
43. COVID-19 anosmia and gustatory symptoms as a prognosis factor: a subanalysis of the HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID-19) registry
44. A Prospective Multicenter Randomized Trial to Assess the Effectiveness of the MagicTouch Sirolimus-Coated Balloon in Small Vessels: Rationale and Design of the TRANSFORM I Trial
45. Drug-Coated Balloon Versus Drug-Eluting Stent for Small Coronary Vessel Disease: PICCOLETO II Randomized Clinical Trial
46. IntravaScular Lithotripsy for the Management of UndILatable Coronary StEnt: The SMILE Registry
47. Prevalence and quantitative assessment of macrophages in coronary plaques
48. Coronary stent failure: role of a blended approach with drug-coated balloons for complex lesions.
49. Incidence of Adverse Events at 3 Months Versus at 12 Months After Dual Antiplatelet Therapy Cessation in Patients Treated With Thin Stents With Unprotected Left Main or Coronary Bifurcations
50. Gender differences in the development of heart failure after acute coronary syndrome: Insight from the CORALYS registry
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.